The report predicts the global Apheresis Market to grow with a CAGR of 11.00% over the forecast period from 2022 to 2031.
Apheresis is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of the separated components. This process involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. The global market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2031 growing at a CAGR of 11.0% from 2022 to 2031. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.
This market is driven by the advantages of apheresis collection over whole blood collection, huge demand for plasma in plasma fractionation, and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market.
North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with a large populations.
Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-59159
The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.
Scope of the Report
The research report categorizes this market into the procedure, application, technology, product type, and end-user. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011, and 2012, as well as forecast up to 2031. Each of the apheresis markets is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and the Rest of the World) to provide in-depth information on the global scenario.
Global Market segmentation:
Blood Disorders (TTP, Leukemia, & Others)
Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others)
Others (photopheresis, lipidpheresis, and Immunoadsoption)
By Product type:
Blood banks/Blood collection centers
Hospitals & Hospital attached blood banks
Get The Sample PDF Report Here For More Insights: https://www.sdki.jp/sample-request-59159
RoW (Rest of the World)
Each section of the report also provides market trends with respect to drivers, restraints, and opportunities. The report includes 13 company profiles and its competitive landscape section sketches the strategic developments in the market.
-Related Trending Reports:-